Side-by-side comparison of AI visibility scores, market position, and capabilities
Global electronics component distributor with $35B revenue; supply chain intermediary for 175K customers connecting OEM buyers with 1,000+ component manufacturers competing with Avnet.
Arrow Electronics is a global distributor of electronic components and enterprise computing solutions — serving as the supply chain intermediary between component manufacturers (Intel, Broadcom, Analog Devices, Molex) and engineers and buyers at original equipment manufacturers (OEMs), contract manufacturers, and other companies that build electronic products. Listed on NYSE (NYSE: ARW) and headquartered in Centennial, Colorado, Arrow generates approximately $35 billion in annual revenue through two segments: Electronic Components and Enterprise Computing Solutions.\n\nArrow's Electronic Components segment provides passive, active, and electromechanical components (resistors, capacitors, microprocessors, power semiconductors, connectors, cables) alongside design engineering services and supply chain management for electronics manufacturers globally. Arrow maintains relationships with 175,000+ customers and 1,000+ supply partners, providing the scale that allows small and mid-sized electronics manufacturers to access the same component supply chain as large companies. The Enterprise Computing Solutions segment distributes software, storage, servers, and cloud solutions.\n\nIn 2025, Arrow competes primarily with Avnet (the other large global electronics distributor) for electronic component distribution market share, and with TD Synnex and Ingram Micro for IT product distribution. The semiconductor distribution market is affected by supply chain volatility — the 2021-2022 chip shortage created massive demand for distributors' buffer stock management services, while the subsequent 2023-2024 normalization created inventory excess. Arrow's 2025 strategy focuses on growing value-added services (application-specific design support, supply chain optimization), expanding in the embedded and IoT design ecosystem, and growing its Arrow.com digital commerce channel for component purchasing.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.